Tiffany net rises, but revenue misses market forecasts

Article Abstract:

Tiffany and Co. of the United States posted profit increases of 37 percent to $23.8 million up from $17.4 million last year. The legendary jewellry maven was buoyed by sales for luxury pieces, particularly platinum and coloured diamonds. Revenue increased 8.4 percent to $500.1 million from $461.2 million a year ago.

MISCELLANEOUS RETAIL, HOME FURNITURE, FURNISHINGS, AND EQUIPMENT STORES, Company Profile, Specialty stores, Tiffany & Co.

---

Store sales are chilled by winter weather: economic concerns impede spending; a Wal-Mart miss

Article Abstract:

Extremely cold winter weather has negatively affected clothing retail sales in the United States, leading to fears about future consumer spending. Wal-Mart Stores Inc. has also experienced soft sales lately, and is forecasting continued weak sales for spring.

Apparel & Shoe Stores, Clothing and Clothing Accessories Stores, APPAREL AND ACCESSORY STORES, Economic aspects, Winter, Clothing stores

---

Wal-Mart pegs growth on overseas arm: profit and sales climb despite U.S. softness; view shows confidence

Article Abstract:

Strong international sales are helping to offset the weak performance of Wal-Mart Stores Inc.'s U.S. stores., with fourth-quarter profits rising 9.8%. The company is predicting continued increases for the first quarter.

Foreign operations, Forecasts, trends, outlooks, Company business forecast/projection, Company forecasts, Financial report

Similar abstracts:

• Abstracts: Estimating the market shares of stores based on the shopper's search and purchase behavior. Optimal management of cross-trained workers in services with negligible switching costs
• Abstracts: Lusiteca Supergorila Tutti Frutti Pastilhas Elasticas. Clorets Freshmint Goma de Mascar
• Abstracts: Palestinian shares flourish. Outside audit: behind the British debt magic; some overloaded U.K. consumers are shrinking credit-card bills, eroding profits of the lenders
• Abstracts: Nestle Smarties Pocket Melkchocolade Dragees. Hellmann's 0% Colesterol Maionese
• Abstracts: SkyePharma attracts interest. AstraZeneca is on prowl outside its own lab walls. Big drug makers take a pass on Serono

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.